Clinical Trial: A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in Healthy Adults With Elevated LDL-C Levels

U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07423598) titled 'A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in Healthy Adults With Elevated LDL-C Levels' on Feb. 13.

Brief Summary: The purpose of this study is to evaluate pharmacodynamics (PD) of AZD0780 compared with placebo by assessment of low-density lipoprotein-cholesterol (LDL-C) levels following repeated oral dosing in healthy adults with elevated LDL-C levels.

Study Start Date: Feb. 24

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: AZD0780

AZD0780 will be administered orally.

DRUG: Placebo

Placebo will be a...